PBS access to alendronate widened

Thousands more elderly patients are now eligible for subsidised osteoporosis therapy, an expert says, following an expansion of the PBS criteria for alendronate.

Patients aged 70 years or older with no prior fracture can now receive the bisphosphonate if they have a BMD T-score of -2.5 or less, as opposed to the previous restriction of -3.0 or less.

Professor John Eisman, an endocrinologist at St Vincent's Hospital in Sydney, said patients could now be proactive about getting treated for osteoporosis, rather than wait until their condition